News

Amph, Iron Sucrose and FDA Approval

Amphastar raised to Buy at Needham on iron sucrose injection approval
Amphastar Pharmaceuticals (NASDAQ:AMPH) has been upgraded to Buy from Hold at Needham after getting FDA approval for its generic iron sucrose injection to treat anemia associated with chronic kidney disease.
Amphastar Secures FDA Nod For Iron Sucrose Injection, Analysts Eye Major Sales Momentum
On Monday, the U.S. Food and Drug Administration (FDA) approved Amphastar Pharmaceuticals, Inc.’s (NASDAQ:AMPH) Abbreviated New Drug Application (ANDA) for Iron Sucrose Injection, USP 50mg/2.5mL, 100mg/5mL,
Amphastar Shares Rise Following FDA Approval of Generic Iron Sucrose Injection
Amphastar Pharmaceuticals (NASDAQ:AMPH) saw its stock increase by 4% after the company announced that the FDA had approved its generic version of iron sucrose injection, a treatment used for iron deficiency anemia in patients with chronic kidney disease.
Amphastar Announces FDA Approval for Iron Sucrose Injection, USP
According to the FDA, Amphastar's iron sucrose injection meets the criteria for bioequivalence and therapeutic equivalence to Venofer ®for the treatment of iron deficiency anemia in patients with chronic kidney disease RANCHO CUCAMONGA,
FDA Approves First Generic Version of Venofer Injection
Iron sucrose injection is an iron replacement product indicated for the treatment of iron deficiency anemia in patients with chronic kidney disease.
Viatris, Amphastar Pharmaceuticals Get FDA Approvals of Iron Sucrose Products
Venofer was approved in the U.S. in 2000. It was developed by Vifor Pharma, which is now part of CSL Ltd. American Regent, a unit of Daiichi Sankyo, manufactures and sells it in the U.S. under a license agreement.
Viatris Announces Approval of First Generic Iron Sucrose Injection in the U.S.
Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced the U.S. Food and Drug Administration (FDA) has approved Iron Sucrose Injection, USP, an intravenous iron replacement product used to treat iron deficiency anemia (IDA) in adult and pediatric patients (2 years of age and older) with chronic kidney disease (CKD).
Amphastar gets FDA nod for generic iron sucrose injection
Amphastar Pharmaceuticals (NASDAQ:AMPH) said that the FDA approved its generic iron sucrose injection, USP 50mg/2.5mL, 100mg/5mL, and 200mg/10mL, to treat anemia in patients with chronic kidney disease.
Fierce Pharma13h

CSL's Venofer finally faces generic competition as FDA clears copycats from Viatris, Sandoz and Amphastar

Generic versions of CSL’s iron replacement therapy Venofer have arrived in the U.S. after a yearslong wait. | Generic ...
Healthline7y

Sucrose vs. Glucose vs. Fructose: What’s the Difference?

Sucrose, glucose, and fructose are three types of sugar that contain the same number of calories gram for gram. They’re all found naturally in fruits, vegetables, dairy products, and grains but ...

A Coca-Cola product will use cane sugar, not high-fructose corn syrup. Experts weigh in on the difference

Coca-Cola announced it is making a version with cane sugar instead of high-fructose corn syrup. Here’s what research says ...
ucdavis.edu3y

Both Sucrose and High Fructose Corn Syrup Linked to ... - UC Davis

Consuming sucrose, the more “natural form of sugar,” may be as bad for your health as consuming high fructose corn syrup, according to a University of California, Davis, study published in the ...
WebMD1y

Sucrose vs. Fructose: What’s the Difference? - WebMD

Sucrose is a disaccharide made of glucose and fructose. It’s commonly known as “table sugar” but it can be found naturally in fruits, vegetables, and nuts.